Rocky Mountain Eye Center PC
Rocky Mountain Eye Center PC was paid $1.96M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 92004, Ophthalmological services: medical examination and evaluation, comprehensive, new patient — 32% of everything it billed.
33Billing provider infoROCKY MOUNTAIN EYE CENTER PC
MISSOULA, MT 59801
MISSOULA, MT 59801
33aNPI1740291350assigned 08/10/2006
33bProvider typeOptometrist
28Total paid$1.96M
24GClaims91,147
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Optometrist providers in Montana
Rank by total paid#1 of 113
Median peer was paid$95K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,251 | $164K | |
| 2019 | 13,651 | $215K | |
| 2020 | 10,318 | $156K | |
| 2021 | 12,493 | $200K | |
| 2022 | 21,515 | $388K | |
| 2023 | 21,089 | $399K | |
| 2024incomplete | 7,830 | $434K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 32% | 5,800 | 5,545 | $628K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 30% | 6,458 | 6,237 | $580K |
| 92015 | Determination of refractive state | 11% | 15,041 | 14,461 | $219K |
| 67028 | Intravitreal injection of a pharmacologic agent | 8.2% | 4,052 | 2,876 | $161K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.1% | 2,288 | 1,922 | $140K |
| 92134 | 4.1% | 4,323 | 3,637 | $80K | |
| J9035 | Injection, bevacizumab, 10 mg | 3.3% | 2,208 | 1,760 | $65K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 515 | 466 | $32K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.4% | 577 | 464 | $27K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 88 | 87 | $13K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | <1% | 14 | 14 | $7K |
| 92250 | <1% | 114 | 112 | $3K |
25 more codes
| 92060 | <1% | 27 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $832.77 |
| 92133 | <1% | 12 | $311.60 | |
| 92020 | <1% | 15 | $247.52 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 8,244 | $4.60 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 435 | $4.60 |
| G8785 | Blood pressure reading not documented, reason not given | <1% | 12,270 | $0.01 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 12,381 | $0.01 |
| 1036F | 0% | 8,816 | $0.00 | |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 452 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 3,227 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 918 | $0.00 |
| 4177F | 0% | 124 | $0.00 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 127 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 32 | $0.00 |
| 3285F | 0% | 26 | $0.00 | |
| 3284F | 0% | 41 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 12 | $0.00 |
| 0517F | 0% | 116 | $0.00 | |
| 5010F | 0% | 171 | $0.00 | |
| 2022F | 0% | 840 | $0.00 | |
| 2024F | 0% | 786 | $0.00 | |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 119 | $0.00 |
| 2026F | 0% | 454 | $0.00 | |
| 2027F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROE, KIM (BILLING DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Rocky Mountain Optical & Contact Lens Center, INC. | Missoula, MT | $340K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.